Skip to main content
. 2017 Apr;361(1):99–108. doi: 10.1124/jpet.116.239459

Fig. 7.

Fig. 7.

BH4 levels in control nonischemic hearts and vehicle-treated or luteolinidin-treated hearts after I/R. After I/R, BH4 levels were higher in liposomal luteolinidin-treated hearts (25 μM Lut) compared with hearts receiving vehicle of empty liposome-treatment (I/R). **P < 0.01; P < 0.05 (with respect to nonischemic control and I/R, respectively; mean ± S.E.M., n = 3–7).